Načítá se...
Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome. The 2016 ATS Bear Cage Award–winning Proposal
After dozens of clinical trials, there are still no Food and Drug Administration–approved drugs that improve mortality in acute respiratory distress syndrome (ARDS). These poor results may be caused in part by three unique pharmacological challenges presented by ARDS: (1) Patients with ARDS are frag...
Uloženo v:
| Vydáno v: | Ann Am Thorac Soc |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Thoracic Society
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5427718/ https://ncbi.nlm.nih.gov/pubmed/28304180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201701-090PS |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|